Ivan Kairatov is a leading biopharma expert whose career has been defined by bridging the gap between raw material science and clinical application. With extensive experience in research and development, he specializes in how emerging technologies—like advanced sensors and AI—can transform our
Ivan Kairatov is a distinguished biopharmaceutical expert with a formidable track record in research and development, specifically focusing on the intersection of technological innovation and clinical strategy. With years of experience navigating the complexities of large-scale vaccine trials and
The field of pediatric surgery is currently witnessing a paradigm shift, moving away from purely mechanical repairs toward the biological reconstruction of complex organs. For children born with long-gap esophageal atresia, the challenge has always been the physical impossibility of connecting two
Lukas Hainz sits down with Ivan Kairatov, a distinguished biopharma expert with a deep background in research and development and a keen eye for technological innovation within the pharmaceutical industry. Together, they explore a recent breakthrough from the University of Cambridge that reimagines
Ivan Kairatov is a distinguished biopharma expert with a career built on navigating the intricate crossroads of biotechnology innovation and regulatory strategy. With extensive experience in research and development, he has spent years analyzing how emerging therapies transition from the laboratory
The journey following a stem cell transplant can be fraught with complications, none more debilitating than chronic graft-versus-host disease, a condition where donor immune cells relentlessly attack the recipient's body. This review assesses Rezurock (belumosudil) as a critical therapeutic option
